Company: OSRH
Filing Date: 2025-06-23
Form Type: 424B3
Source: 0001213900-25-056351
Chunk: 108

Company: OSR Holdings, Inc.
Filing Date: 2025-06-23
Form: 424B3
Chunk 108
---
-sector career
from 1994 through 2001 during which time he was able to participate in global trade negotiation projects in the field of agricultural
goods, and he also joined the Korean National Negotiation Team to represent South Korea in multilateral trade communications such as
WTO, APEC and Bilateral Trade Consultations (FTA). Mr. Kim earned his MBA degree from Georgetown University in 2001, and his M.A.
(Public Policy) and B.S. (International Economics) from Seoul National University. Mr. Kim is well qualified to serve as a Director
because of his extensive experience in both legal and investment sectors across various asset classes, demonstrating significant expertise
in capital market.

Hyuk Joo Jee became a Director of
the Company upon the Closing of the Business Combination. Mr. Jee has served as a Special Advisor to Chairman at DongKoo Bio Pharma
Co., Ltd., a public company in Korea, since January 2024. Prior to joining DongKoo Bio Pharma, Mr. Jee served with HLB Co.,
Ltd., also a publicly-listed biopharmaceutical company in Korea, as Chief Operating Officer and the Head of Corporate Private Equity
leading the firm’s investments and resource allocations over a global pipeline of clinical-stage oncology programs from August 2018
through December 2023. During his tenure at HLB, Mr. Jee led the firm’s global IR, M&As and strategic investment
activities. Prior to his careers in the biopharmaceutical industry, Mr. Jee has spent more than 15 years serving with brokerage
and investment banking firms, mostly representing their European offices and providing services to the European and global fund clients
investing in Korean equities market. Those engagements include Korea Investment Securities Europe (London), Daewoo Securities Europe
(London), and Hyundai Securities Europe (London and Seoul) between July 2002 and January 2018. Mr. Jee has started his
finance career as an Analyst and Portfolio Manager at Scudder Kemper and Schroders based in Seoul, Korea serving from 1998 to 2002. Mr. Jee
has received his B.A. in Business Administration from the Korea University in 1994. Mr. Jee is well qualified to serve as a Director
because of his well-balanced career between finance and biopharmaceutical industries, especially leading M&A transactions while
serving from executive positions with his previous employer.

<div align='center'>65</div>